Involvement of P-glycoprotein and cytochrome p450 3A in the metabolism of florfenicol of rabbits

Journal of Veterinary Pharmacology and Therapeutics

Volumn 35, Issue 2, 2012, Pages 202-205

  Liu, N ^a   Guo, M ^a   Mo, F ^a   Sun, Y H ^a   Yuan, Z ^a   Cao, L H ^a   Jiang, S X ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A; FLORFENICOL; FLUVOXAMINE; GLYCOPROTEIN P; KETOCONAZOLE; VERAPAMIL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTI-BACTERIAL AGENTS; CYTOCHROME P-450 CYP3A; FLUVOXAMINE; KETOCONAZOLE; P-GLYCOPROTEIN; RABBITS; THIAMPHENICOL; VERAPAMIL;

ORYCTOLAGUS CUNICULUS;

EID: 84858001474     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2011.01310.x     Document Type: Article

References (40)

1. Abd El-Aty, A.M., Goudah, A., El-Sooud, K., El-Zorba, H.Y., Shimoda, M. & Zhou, H.H. (2004) Pharmacokinetics and bioavailiability of florfenicol following intravenous, intramuscular and oral administrations in rabbits. Veterinary Research Communications, 28, 515-524.
2. Afifi, N.A. & Abo El-Sooud, K.A. (1997) Tissue concentrations and pharmacokinetics of florfenicol in broiler chickens. British Poultry Science, 38, 425-428.
3. Atef, M., El-genda, Y.I., Amer, A.M.M. & El-aty, A.M.A. (2001) Disposition kinetics of florfenicol in goats by using two analytical methods. Journal of Veterinary Medicine. A, Physiology, Pathology, Clinical Medicine, 48, 129-136.
4. Ayling, R.D., Baker, S.E., Peek, M.L., Simon, A.J. & Nicholas, R.A. (2000) Comparison of in vitro activity of danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin against recent field isolates of Mycoplasma bovis. Veterinary Record, 146, 745-747.
5. Backman, J.T., Olkkola, K.T., Aranko, K., Himberg, J.J. & Neuvonen, P.J. (1994) Dose of midazolam should be reduced during diltiazem and verapamil treatments. British Journal of Clinical Pharmacology, 37, 221-225.
6. Cannon, M., Harford, S. & Davies, J. (1990) A comparative study on the inhibitory actions of chloramphenicol, thiamphenicol and some fluorinated derivatives. Journal of Antimicrobial Chemotherapy, 26, 307-317.
7. Cousein, E., Barthélémy, C., Poullain, S., Simon, N., Lestavel, S., Williame, V., Joiris, E., Danel, C., Clavey, V., Brossard, D., Robert, H., Crauste-Manciet, S., Vaccher, C. & Odou, P. (2007) P-glycoprotein and cytochrome P450 3A4 involvement in risperidone transport using an in vitro Caco-2/TC7 model and an in vivo model. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31, 878-886.
8. Fang, H., Xu, J., Mei, Q., Diao, L., Chen, M., Jin, J. & Xu, X. (2009) Involvement of cytochrome P450 3A4 and P-glycoprotein in first-pass intestinal extraction of omeprazole in rabbits. Acta Pharmacologica Sinica, 30, 1566-1572.
9. Guerre, P., Pineau, T., Costet, P., Burgat, V. & Galtier, P. (2000) Effects of AFB1 on CYP 1A1, 1A2 and 3A6 mRNA, and P450 expression in primary culture of rabbit hepatocytes. Toxicology Letters, 111, 243-251.
10. Kantola, T., Kivisto, K.T. & Neuvonen, P.J. (1998) Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations. Clinical Pharmacology and Therapeutics, 64, 177-182.
11. Koc, F., Ozturk, M., Kadioglu, Y., Dogan, E., Yanmaz, L.E. & Okumus, Z. (2009) Pharmacokinetics of florfenicol after intravenous and intramuscular administration in New Zealand White rabbits. Research in Veterinary Science, 87, 102-105.
12. Kowalski, P., Konieczna, L., Chmielewska, A., Oledzka, I., Plenis, A., Bieniecki, M. & Lamparczyk, H. (2005) Comparative evaluation between capillary electrophoresis and high-performance liquid chromatography for the analysis of florfenicol. Journal of Pharmaceutical and Biomedical Analysis, 39, 983-989.
13. Lamberg, T.S., Kivisto, K.T. & Neuvonen, P.J. (1998) Effects of verapamil and diltiazem on the pharmacokinetics and pharmacodynamics of buspirone. Clinical Pharmacology and Therapeutics, 63, 640-645.
14. Li, D., Yang, X.L., Zhang, S.J., Lin, M., Yu, W.J. & Hu, K. (2008) Effects of mammalian CYP3A inducers on CYP3A-related enzyme activities in grass carp (Ctenopharyngodon idellus): possible implications for the establishment of a fish CYP3A induction model. Comparative Biochemistry and Physiology. Toxicology & Pharmacology: CBP, 147, 17-29.
15. Marini, S., Nannelli, A., Sodini, D., Dragoni, S., Valoti, M., Longo, V. & Gervasi, P.G. (2007) Expression, microsomal and mitochondrial activities of cytochrome P450 enzymes in brain regions from control and phenobarbital-treated rabbits. Life Sciences, 80, 910-917.
16. Marshall, S.A., Jones, R.N., Wanger, A., Washington, J.A., Doern, G.V., Leber, A.L. & Haugen, T.H. (1996) Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin and spectinomycin. Journal of Clinical Microbiology, 34, 2027-2029.
17. Mirghani, R.A., Hellgren, U., Westerberg, P.A., Ericsson, O., Bertilsson, L. & Gustafsson, L.L. (1999) The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivo. Clinical Pharmacology and Therapeutics, 66, 454-460.
18. Olkkola, K.T., Isohanni, M.H., Hamunen, K. & Neuvonen, P.J. (2005) The effect of erythromycin and fluvoxamine on the pharmacokinetics of intravenous lidocaine. Anesthesia and Analgesia, 100, 1352-1356.
19. Pal, D. & Mitra, A.K. (2006) MDR- and CYP3A4-mediated drug-drug interactions. Journal of Neuroimmune Pharmacology, 1, 323-339.
20. Park, B.K., Kitteringham, N.R., Pirmohamed, M. & Tucker, G.T. (1996) Relevance of induction of human drug-metabolizing enzymes: pharmacological and toxicological implications. British Journal of Clinical Pharmacology, 41, 477-491.
21. Park, B.K., Lim, J.H., Kim, M.S., Hwang, Y.H. & Yun, H.I. (2007) Pharmacokinetics of florfenicol and its major metabolite, florfenicol amine, in rabbits. Journal of Veterinary Pharmacology and Therapeutics, 30, 32-36.
22. Quattrocchi, L.C. & Guzelian, P.S. (2001) CYP3A regulation: from pharmacology to nuclear receptors. Drug Metabolism and Disposition, 29, 615-622.
23. Rahal, A., Kumar, A., Ahmad, A.H. & Malik, J.K. (2008) Pharmacokinetics of diclofenac and its interaction with enrofloxacin in sheep. Research in Veterinary Science, 84, 452-456.
24. Regmi, N.L., Abd El-Aty, A.M., Kuroha, M., Nakamura, M. & Shimoda, M. (2005) Inhibitory effect of several fluoroquinolones on hepatic microsomal cytochrome P-450 1A activities in dogs. Journal of Veterinary Pharmacology and Therapeutics, 28, 553-557.
25. Regmi, N.L., Abd El-Aty, A.M., Kubota, R., Shah, S.S. & Shimoda, M. (2007) Lack of inhibitory effects of several fluoroquinolones on cytochrome P-450 3A activities at clinical dosage in dogs. Journal of Veterinary Pharmacology and Therapeutics, 30, 37-42.
26. Shen, J., Hu, D., Wu, X. & Coats, J.R. (2003) Bioavailability and pharmacokinetics of florfenicol in broiler chickens. Journal of Veterinary Pharmacology and Therapeutics, 26, 337-341.
27. Smith, E.M. & Wilson, J.Y. (2010) Assessment of cytochrome P450 fluorometric substrates with rainbow trout and killifish exposed to dexamethasone, pregnenolone-16alpha-carbonitrile, rifampicin, and beta-naphthoflavone. Aquatic Toxicology, 97, 324-333.
28. Soback, S., Paape, M.J., Filep, R. & Varma, K.J. (1995) Florfenicol pharmacokinetics in lactating cows after intravenous, intramuscular and intramammary administration. Journal of Veterinary Pharmacology and Therapeutics, 18, 413-417.
29. Spigset, O., Granberg, K., Hägg, S., Norström, A. & Dahlqvist, R. (1997) Relationship between fluvoxamine pharmacokinetics and CYP2D6/CYP2C19 phenotype polymorphisms. European Journal of Clinical Pharmacology, 52, 129-133.
30. Ueda, Y., Ohtsuki, S. & Narukawa, N. (1995) Efficacy of florfenicol on experimental Actinobacillus pleuropneumonia in pigs. Journal of Veterinary Medical Science, 57, 261-265.
31. Venkatakrishnan, K., von Moltke, L.L. & Greenblatt, D.J. (2000) Effects of the antifungal agents on oxidative drug metabolism. Clinical Pharmacokinetics, 38, 111-180.
32. Voorspoels, J., D'Haese, E., De Craene, B.A., Vervaet, C., De Riemaecker, D., Deprez, P., Nelis, H. & Remon, J.P. (1999) Pharmacokinetics of florfenicol after treatment of pigs with single oral or intramuscular doses or with medicated feed for three days. Veterinary Record, 154, 397-399.
33. Weiss, J., Dormann, S.M., Martin-Facklam, M., Kerpen, C.J., Ketabi-Kiyanvash, N. & Haefeli, W.E. (2003) Inhibition of P-glycoprotein by newer antidepressants. Journal of Pharmacology and Experimental Therapeutics, 305, 197-204.
34. Yamaoka, K., Nakagawa, T. & Uno, T. (1978) Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics, 6, 165-175.
35. Yang, Y.C., Zhang, W.G., Tang, Z.M., Liu, C.X., Sun, R.Y. & Yu, Z.L. (1988) 3P87 practical pharmacokinetics program. Information of the Chinese Pharmacological Society, 5, 67.
36. Yao, C., Kunze, K.L., Kharasch, E.D., Wang, Y., Trager, W.F., Ragueneau, I. & Levy, R.H. (2001) Fluvoxamine-theophylline interaction: gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2. Clinical Pharmacology and Therapeutics, 70, 415-424.
37. Yasui-Furukori, N., Takahata, T., Nakagami, T., Yoshiya, G., Inoue, Y., Kaneko, S. & Tateishi, T. (2004) Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes. British Journal of Clinical Pharmacology, 57, 487-494.
38. Zhang, L.L., Zhang, J.R., Guo, K., Ji, H., Zhang, Y. & Jiang, S.X. (2011) Effects of fluoroquinolones on CYP4501A and 3A in male broilers. Research in Veterinary Science, 90, 99-105.
39. Zhao, H.Y., Zhang, G.H., Bai, L., Zhu, S., Shan, Q., Zeng, D.P. & Sun, Y.X. (2011) Pharmacokinetics of florfenicol in crucian carp (Carassius auratus cuvieri) after a single intramuscular or oral administration. Journal of Veterinary Pharmacology and Therapeutics, 34, DOI:.
40. Zhou, S.F. (2008) Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Current Drug Metabolism, 9, 310-322.